Healthcare Realty Trust (NYSE:HR) Issues FY25 Earnings Guidance

Healthcare Realty Trust (NYSE:HR) issued an update on its FY25 earnings guidance on Wednesday morning. The company provided earnings per share guidance of $1.56 to $1.60 for the period, compared to the consensus earnings per share estimate of $1.59. Healthcare Realty Trust also updated its FY 2025 guidance to 1.560-1.600 EPS.

Healthcare Realty Trust Price Performance

Shares of NYSE:HR traded down $0.22 on Thursday, hitting $16.56. 433,887 shares of the company’s stock were exchanged, compared to its average volume of 2,340,432. Healthcare Realty Trust has a 12 month low of $12.77 and a 12 month high of $18.90. The stock has a market capitalization of $5.87 billion, a price-to-earnings ratio of -10.47 and a beta of 0.94. The business’s 50 day simple moving average is $16.68 and its two-hundred day simple moving average is $17.42.

Healthcare Realty Trust (NYSE:HR) last released its earnings results on Wednesday, February 19th. The real estate investment trust reported $0.40 earnings per share for the quarter, topping the consensus estimate of $0.39 by $0.01. The business had revenue of $309.77 million during the quarter, compared to the consensus estimate of $303.81 million. Healthcare Realty Trust had a negative return on equity of 9.42% and a negative net margin of 45.63%. The business’s revenue for the quarter was down 6.3% compared to the same quarter last year. During the same period last year, the company earned $0.39 earnings per share. Equities analysts forecast that Healthcare Realty Trust will post 1.55 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on HR shares. Wedbush lowered Healthcare Realty Trust from a “neutral” rating to an “underperform” rating and cut their target price for the company from $18.00 to $16.00 in a research note on Thursday, January 2nd. JPMorgan Chase & Co. lowered Healthcare Realty Trust from an “overweight” rating to a “neutral” rating and set a $19.00 target price on the stock. in a research note on Friday, December 20th. Finally, Jefferies Financial Group lowered Healthcare Realty Trust from a “buy” rating to a “hold” rating and cut their target price for the company from $19.00 to $17.00 in a research note on Thursday, January 2nd. Two analysts have rated the stock with a sell rating and four have issued a hold rating to the stock. Based on data from MarketBeat, Healthcare Realty Trust presently has an average rating of “Hold” and an average target price of $17.00.

Insider Buying and Selling at Healthcare Realty Trust

In other Healthcare Realty Trust news, COO Robert E. Hull sold 10,000 shares of the firm’s stock in a transaction on Tuesday, December 17th. The stock was sold at an average price of $17.48, for a total value of $174,800.00. Following the completion of the sale, the chief operating officer now directly owns 171,400 shares of the company’s stock, valued at $2,996,072. This trade represents a 5.51 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Thomas N. Bohjalian bought 7,750 shares of the business’s stock in a transaction on Friday, November 22nd. The stock was bought at an average cost of $17.39 per share, with a total value of $134,772.50. Following the completion of the purchase, the director now directly owns 50,002 shares in the company, valued at approximately $869,534.78. The trade was a 18.34 % increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last 90 days, insiders have bought 18,750 shares of company stock worth $323,723. Corporate insiders own 0.56% of the company’s stock.

About Healthcare Realty Trust

Healthcare Realty Trust, Inc provides real estate investment services. It owns, leases, manages, acquires, finances, develops, and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States of America. The company was founded by David R.